Lv7
3230 积分 2022-02-16 加入
Discovery of AZD3514, a small-molecule androgen receptor downregulator for treatment of advanced prostate cancer
7天前
已完结
Potent and selective bivalent inhibitors of BET bromodomains
7天前
已完结
Nineteen-step total synthesis of (+)-phorbol
1个月前
已完结
Overview of PROTACs Targeting the Estrogen Receptor: Achievementsfor Biological and Drug Discovery
3个月前
已完结
Mechanistic insights from comparing intrinsic clearance values between human liver microsomes and hepatocytes to guide drug design
3个月前
已完结
Selective inhibition of the BD2 bromodomain of BET proteins in prostate cancer
4个月前
已完结
25LBA Impact of baseline genetic heterogeneities on progression-free survival (PFS) in patients (pts) with advanced BRAFV600-mutated melanoma treated with cobimetinib (COBI) + vemurafenib (VEM) in the phase 3 coBRIM study
4个月前
已关闭
The state of the art in secondary pharmacology and its impact on the safety of new medicines
4个月前
已完结
Atropisomerism in Medicinal Chemistry: Challenges and Opportunities
5个月前
已完结
Prolonged and tunable residence time using reversible covalent kinase inhibitors
5个月前
已完结
皖公网安备34019202002308
